Upload
md-specialclass
View
2.415
Download
0
Tags:
Embed Size (px)
DESCRIPTION
Citation preview
GETTING AHEAD OF GETTING AHEAD OF HEADACHESHEADACHES
Ruben T. Dela Cruz MD FPNARuben T. Dela Cruz MD FPNA
Acute Stroke Unit - Manila Adventist Medical Acute Stroke Unit - Manila Adventist Medical CenterCenter
HEADACHES OR HEADPAINSHEADACHES OR HEADPAINS
• 90% OF INDIVIDUALS – AT LEAST ONE HEADACHE PER YEAR90% OF INDIVIDUALS – AT LEAST ONE HEADACHE PER YEAR
• 40% OF INDIVIDUALS WORLDWIDE – SEVERE, DISABLING HA 40% OF INDIVIDUALS WORLDWIDE – SEVERE, DISABLING HA ANUALLYANUALLY
• 5% OF EMERGENCY CASES OF HA – SERIOUS UNDERLYING 5% OF EMERGENCY CASES OF HA – SERIOUS UNDERLYING NEUROLOGICNEUROLOGIC
DISORDERDISORDER
COMMUNITY PREVALENCE OF COMMUNITY PREVALENCE OF HEADACHEHEADACHE
• PRIMARY HEADACHESPRIMARY HEADACHES
TYPETYPE PREVALENCEPREVALENCE
MigraineMigraine 16% 16% Tension- typeTension- type 69% 69% Cluster headacheCluster headache 0.1% 0.1% Idiopathic- stabbingIdiopathic- stabbing 2% 2% Exert ionalExert ional 1% 1%
COMMUNITY PREVALENCE COMMUNITY PREVALENCE OF HEADACHESOF HEADACHES
• SECONDARY HEADACHESSECONDARY HEADACHES
TYPETYPE PREVALENCEPREVALENCE
Systemic infectionSystemic infection 63%63%
Head injuryHead injury 4% 4%
Subarachnoid hemorrhageSubarachnoid hemorrhage 1% 1%
Vascular disorderVascular disorder 1% 1%
Brain tumorBrain tumor 0.1% 0.1%
PAINFUL BUT BENIGN HEADACHES PAINFUL BUT BENIGN HEADACHES (PRIMARY HEADACHES)(PRIMARY HEADACHES)
• MIGRAINEMIGRAINE
• CLUSTER HEADACHECLUSTER HEADACHE
• TENSION-TYPE HEADACHETENSION-TYPE HEADACHE
• BENIGN EXERTIONAL HABENIGN EXERTIONAL HA
• ORGASMIC HAORGASMIC HA
SERIOUS HEADACHE SERIOUS HEADACHE (SECONDARY HEADACHES)(SECONDARY HEADACHES)• Raised Intracranial pressure from any causeRaised Intracranial pressure from any cause• CNS infections (meningitis, encephalitis)CNS infections (meningitis, encephalitis)• Subarachnoid hemorrhageSubarachnoid hemorrhage• Cranial arteritis (eg. Giant cell arteritis)Cranial arteritis (eg. Giant cell arteritis)• Metabolic disturbances (ie. hypoglycemia, carbon Metabolic disturbances (ie. hypoglycemia, carbon
monoxide poisoning)monoxide poisoning)• Pheochromocytoma and malignant hypertensionPheochromocytoma and malignant hypertension• Acute glaucomaAcute glaucoma• Head traumaHead trauma• Focal CNS ischemia or hemorrhageFocal CNS ischemia or hemorrhage
GENERAL CONSIDERATIONS IN EVALUATING GENERAL CONSIDERATIONS IN EVALUATING HEADACHESHEADACHES
• QUALITYQUALITY
• SEVERITYSEVERITY
• LOCATIONLOCATION
• DURATIONDURATION
• TIME COURSETIME COURSE
• CONDITIONS THAT PRODUCE, EXACERBATE, OR RELIEVE ITCONDITIONS THAT PRODUCE, EXACERBATE, OR RELIEVE IT
HEADACHE SYMPTOMS- SUGGESTING SERIOUS HEADACHE SYMPTOMS- SUGGESTING SERIOUS DISORDERDISORDER
• “Worst” headache ever
• First severe headache
• Sub acute worsening over days or weeks
• Abnormal neurologic examination
• Fever or unexplained systemic signs
• Vomiting precedes headache
• Induced by bending, lifting, coughing
• Disturbs sleep or present immediately upon awakening
• Known systemic illness
• Onset after age 55
SYMPTOMS OF SERIOUS UNDERLYING CAUSES OF SYMPTOMS OF SERIOUS UNDERLYING CAUSES OF HEADACHEHEADACHE
CAUSE SYMPTOMS
Meningitis Nuchal rigidity, headache, photophobia, and prostration; may not be febrile, lumbar puncture is diagnostic
Intracranial hemorrhage
Nuchal rigidity and headache; may not have clouded consciousness or seizures. Hemorrhage may not be seen on CTscan. Lumbar puncture shows “bloody tap” that does not clear by the last tube. A fresh hemorrhage may not be xanthochromic.
Brain tumor May present with prostrating pounding headaches May present with prostrating pounding headaches that are associated with nausea and vomiting. that are associated with nausea and vomiting. Should be suspected in progressively severe new Should be suspected in progressively severe new “migraine” that is invariably unilateral“migraine” that is invariably unilateral
Temporal arteritis
Glaucoma
May present with a unilateral pounding headache. Onset generally in older patients (>50 years) and frequently associated with visual changes. The ESR is the best screening test and is usually markedly elevated (>50). Definitive diagnosis made by arterial biopsy
Usually consists of severe eye pain. May have nausea and vomiting. The eye is usually painful and red. The pupils may be partially dilated.
PAIN-SENSITIVE CRANIAL PAIN-SENSITIVE CRANIAL STRUCTURESSTRUCTURES
• SKIN, SC TISSUE, MUSCLES, EX-SKIN, SC TISSUE, MUSCLES, EX-CRANIAL ARTERIES, PERIOSTEUM OF CRANIAL ARTERIES, PERIOSTEUM OF SKULLSKULL
• EYE, EAR, NASAL CAVITIES, SINUSESEYE, EAR, NASAL CAVITIES, SINUSES
• INTRACRANIAL VENOUS SINUSESINTRACRANIAL VENOUS SINUSES
• BASAL DURA, CIRCLE OF WILLISBASAL DURA, CIRCLE OF WILLIS
• MIDDLE MENINGEAL A., SUPERFICIAL MIDDLE MENINGEAL A., SUPERFICIAL TEMPORAL ARTERIESTEMPORAL ARTERIES
PAIN – SENSITIVE STRUCTURES OF THE PAIN – SENSITIVE STRUCTURES OF THE HEADHEAD
• Distention, traction, or dilatation of intracranial or extracranial Distention, traction, or dilatation of intracranial or extracranial arteriesarteries
• Traction, or displacement of large intracranial veins or their dural Traction, or displacement of large intracranial veins or their dural envelopeenvelope
• Compression, traction, or inflammation of cranial and spinal nervesCompression, traction, or inflammation of cranial and spinal nerves
• Spasm, inflammation, or trauma to cranial and cervical musclesSpasm, inflammation, or trauma to cranial and cervical muscles
• Meningeal irritation and raised intracranial pressureMeningeal irritation and raised intracranial pressure
• Activation of brainstem structures Activation of brainstem structures
NEUROANATOMY OF HEADACHENEUROANATOMY OF HEADACHE
PERIPHERAL INNERVATIONPERIPHERAL INNERVATION
• Trigeminal ganglion (Ophthalmic)- supratentorial Trigeminal ganglion (Ophthalmic)- supratentorial structuresstructures
• Branches of Cervical 2- posterior fossa structuresBranches of Cervical 2- posterior fossa structures
CENTRAL TERMINATIONCENTRAL TERMINATION
• Trigeminocervical complex-caudalis neurons and Trigeminocervical complex-caudalis neurons and neurons of superficial laminae of C1-C2neurons of superficial laminae of C1-C2
• Non-trigeminal projections- brainstem periaqueductal Non-trigeminal projections- brainstem periaqueductal gray and ventroposterior thalamusgray and ventroposterior thalamus
PHYSIOLOGY OF HEAD PAINPHYSIOLOGY OF HEAD PAIN
• Craniovascular vasodilatationCraniovascular vasodilatation• Peripheral trigeminal nerve activationPeripheral trigeminal nerve activation
* Elevation of neuropeptide levels- CGRP (calcitonin * Elevation of neuropeptide levels- CGRP (calcitonin gene-related peptide); substance Pgene-related peptide); substance P* Plasma protein extravasations* Plasma protein extravasations
• Central trigeminal neuronal activationCentral trigeminal neuronal activation* Trigeminal nucleus* Trigeminal nucleus* Non-trigeminal transmission- medial thalamic and* Non-trigeminal transmission- medial thalamic andventroposterior thalamic neuronsventroposterior thalamic neurons
STEPS IN THE OPTIMUM MANAGEMENT STEPS IN THE OPTIMUM MANAGEMENT OF PRIMARY HEADACHESOF PRIMARY HEADACHES
• Make a confident diagnosisMake a confident diagnosis• Assess headache-related disability and impact on Assess headache-related disability and impact on
patients quality of life (QOL).patients quality of life (QOL).• Address behavioral and educational issues in Address behavioral and educational issues in
headache managementheadache management• Discuss and prescribe preventive medications, if Discuss and prescribe preventive medications, if
indicatedindicated• Prescribe an acute treatment based on diagnosis, Prescribe an acute treatment based on diagnosis,
disability assessment and patient’s preferencedisability assessment and patient’s preference• Monitor patient outcomes and modify treatment Monitor patient outcomes and modify treatment
as necessaryas necessary
DRUGS EFFECTIVE IN THE TREATMENT OF TENSION-DRUGS EFFECTIVE IN THE TREATMENT OF TENSION-TYPE HATYPE HA
DRUGDRUG TRADE TRADE NAMENAME
DOSAGEDOSAGE
NONSTEROIDAL ANTIINFLAMMATORY NONSTEROIDAL ANTIINFLAMMATORY AGENTSAGENTS
AcetaminophenAcetaminophen
AspirinAspirin
DiclofenacDiclofenac
IbuprofenIbuprofen
Naprosyn sodiumNaprosyn sodium
COMBINATION ANALGESICSCOMBINATION ANALGESICS
Acetaminophen + butalbitalAcetaminophen + butalbital
Aceta + butalbital + caffeineAceta + butalbital + caffeine
Aspirin + butalbital + cafeineAspirin + butalbital + cafeine
PROPHYLACTIC MEDICATIONSPROPHYLACTIC MEDICATIONS
AmitriptylineAmitriptyline
NortriptylineNortriptyline
DoxepinDoxepin
TylenolTylenol
GenericGeneric
CataflamCataflam
Advil, MotrinAdvil, Motrin
Naproxen,AleNaproxen,Aleveve
PhrenelinPhrenelin
Fioricet, Fioricet, FiorinalFiorinal
ELAVILELAVIL
PamelorPamelor
SinequanSinequan
650 mg PO q4-6h650 mg PO q4-6h
650 mg PO q4-6h650 mg PO q4-6h
50-100 mg q4-6h 50-100 mg q4-6h max 200mg/dmax 200mg/d
400 mg PO q3-4h400 mg PO q3-4h
220-550mg bid220-550mg bid
1-2 tbs mx 6 tbs/d1-2 tbs mx 6 tbs/d
1-2 tbs mx 6 tbs/d1-2 tbs mx 6 tbs/d
1-2 tbs mx 6tbs/d1-2 tbs mx 6tbs/d
10-50 MG at 10-50 MG at BedtimeBedtime
25-75 mg at 25-75 mg at bedtimebedtime
10-75 mg at bt10-75 mg at bt
Symptoms Accompanying Severe Migraine Attacks
• Nausea 87%
• Photophobia 82%
• Lightheadedness 72%
• Scalp tenderness 65%
• Vomiting 56%
• Visual disturbances 36%– Photopsia 26%– Fortification spectra 10%
• Paresthesias 33%
• Vertigo 33%
• Alteration of consciousness 18%– Syncope 10%– Seizure 04%– Confusional state 04%
• Diarrhea 16%
NONPHARMACOLOGIC APROACHES TO NONPHARMACOLOGIC APROACHES TO MIGRAINEMIGRAINE
• Identify and then avoid trigger factors such as:Identify and then avoid trigger factors such as:– Alcohol (e.g. Red wine)Alcohol (e.g. Red wine)– Foods (e.g. chocolate, certain cheeses, monosodium Foods (e.g. chocolate, certain cheeses, monosodium
glutamate, nitrate containing foods)glutamate, nitrate containing foods)– Hunger (avoid missing meals)Hunger (avoid missing meals)– Irregular sleep patterns (both lack of sleep and excessive Irregular sleep patterns (both lack of sleep and excessive
sleep)sleep)– Organic odorsOrganic odors– Sustained exertionSustained exertion– Acute changes in stress levelsAcute changes in stress levels– Miscellaneous (glare, flashing lights)Miscellaneous (glare, flashing lights)
• Attempt to manage environmental shiftsAttempt to manage environmental shifts– Time zone shiftTime zone shift– High altitudeHigh altitude– Barometric pressure changesBarometric pressure changes– Weather changesWeather changes
• Assess menstrual cycle relationshipAssess menstrual cycle relationship
A staged Approach to Migraine Pharmacotherapy
Mild Migraine Occasional throbbing Occasional throbbing headachesheadaches
No major impairment of No major impairment of functioningfunctioning
NSAIDsNSAIDs
Combination Combination analgesicsanalgesics
Oral 5-HT1 agonistsOral 5-HT1 agonists
Moderate Migraine Moderate or severe Moderate or severe headachesheadaches
Nausea commonNausea common
Some impairment of Some impairment of functioningfunctioning
Oral, nasal, or SC 5-Oral, nasal, or SC 5-HT1 agonistHT1 agonist
Oral dopamine Oral dopamine antagonistantagonist
Severe Migraine Severe headaches Severe headaches >3x per month>3x per month
Significant functional Significant functional impairmentimpairment
Marked nausea Marked nausea and/orand/or
vomitingvomiting
SC, IM, or IV 5-HT1 SC, IM, or IV 5-HT1 agonistagonist
IM or IV dopamine IM or IV dopamine antagonistantagonist
Prophylactic Prophylactic medicationsmedications
StageStage DiagnosesDiagnoses TherapiesTherapies
STEP-CARE vs STRATIFIED-CARE in STEP-CARE vs STRATIFIED-CARE in HEADACHE MANAGEMENTHEADACHE MANAGEMENT
• STEP-CARE : Begins at the bottom of therapeutic STEP-CARE : Begins at the bottom of therapeutic pyramid- simple, least expensive agent and pyramid- simple, least expensive agent and escalated according to patient’s need.escalated according to patient’s need.
• STRATIFIED- CARE: Provides a systematic method to STRATIFIED- CARE: Provides a systematic method to match the treatment needs of the patient with the match the treatment needs of the patient with the intensity of treatment.intensity of treatment.
A STAGED APPROACH TO MIGRAINE A STAGED APPROACH TO MIGRAINE PHARMACOTHERAPYPHARMACOTHERAPY
STAGESTAGE DIAGNOSISDIAGNOSIS THERAPIESTHERAPIES
Mild MigraineMild Migraine Occasional throbbing Occasional throbbing HAHA
No major impairment No major impairment of functioningof functioning
NSAIDsNSAIDs
Combination Combination analgesicsanalgesics
Oral 5-HT1 agonistOral 5-HT1 agonist
Moderate MigraineModerate Migraine Moderate or severe Moderate or severe HAHA
Nausea commonNausea common
Some impairment of Some impairment of functioningfunctioning
Oral, nasal r SC 5-HT1 Oral, nasal r SC 5-HT1 agonistagonist
Oral dopamine Oral dopamine antagonistsantagonists
Severe migraineSevere migraine Severe HA >3x / moSevere HA >3x / mo
Significant functional Significant functional impairmentimpairment
Marked nausea Marked nausea and/or vomitingand/or vomiting
SC, IM, or IV 5-HT1 SC, IM, or IV 5-HT1 agonistagonist
IM or IV dopamine IM or IV dopamine antagonistantagonist
Prophylactic Prophylactic medicationsmedications
DRUGS EFFECTIVE IN ACUTE TREATMENT OF DRUGS EFFECTIVE IN ACUTE TREATMENT OF MIGRAINEMIGRAINE
DRUG TRADE NAME DOSAGEDOSAGE
NSAIDs________________NSAIDs________________
Acetaminophen, aspirin, Acetaminophen, aspirin, caffeinecaffeine
Excedrin- MigraineExcedrin- Migraine 2 tab q6h max 8/day2 tab q6h max 8/day
5-HT1 AGONIST5-HT1 AGONIST
ORAL:ORAL:
ErgotamineErgotamine
Ergotamine-Ergotamine-caffeinecaffeine
NaratriptanNaratriptan
RizatriptanRizatriptan
SumatriptanSumatriptan
ZolmitriptanZolmitriptan
ErgomerErgomer
Ercaf; WigraineErcaf; Wigraine
AmergeAmerge
MaxaltMaxalt
Imitrex, ImigranImitrex, Imigran
Zomig (Rapimelt)Zomig (Rapimelt)
0ne 2-mg sl tab at 0ne 2-mg sl tab at onsetand q 1/2h mx onsetand q 1/2h mx 3/d; 5/wk3/d; 5/wk
2.5 mg tb at onset, 2.5 mg tb at onset, rpt after 4 hrsrpt after 4 hrs
5-10 mg at onset rpt 5-10 mg at onset rpt after 2 hrs, mx-after 2 hrs, mx-10mg/d10mg/d
50 to 100 mg tb at 50 to 100 mg tb at onset, rpt after 2 hrs. onset, rpt after 2 hrs. mx 200 mg/dmx 200 mg/d
2.5 mg at onset, rpt 2.5 mg at onset, rpt after 2 hrs, mx after 2 hrs, mx 10mg/d10mg/d
DRUGS EFFECTIVE IN ACUTE TREATMENT OF MIGRAINEDRUGS EFFECTIVE IN ACUTE TREATMENT OF MIGRAINE
5-HT1 agonist5-HT1 agonist
NASALNASAL
DihydroergotamineDihydroergotamine
SumatriptanSumatriptan
PARENTERALPARENTERAL
DihydroergotamineDihydroergotamine
SumatriptanSumatriptan
Migranal nasal sprayMigranal nasal spray
Imitrex nasal sprayImitrex nasal spray
DHE-45DHE-45
Imitrex injImitrex inj
One spray per nostril One spray per nostril then 15 minutes afterthen 15 minutes after
5 to 20 mg spray as 4 5 to 20 mg spray as 4 sprays of 5 mg per sprays of 5 mg per nostril may rpt once nostril may rpt once after 2 hrs. mx after 2 hrs. mx 40mg/d40mg/d
1 mg IV<IM<or SC at 1 mg IV<IM<or SC at onset and q1h mx. onset and q1h mx. 3mg/d; 6mg/wk3mg/d; 6mg/wk
6 mg SC at onset, rpt 6 mg SC at onset, rpt once after 1 hr mx- 2 once after 1 hr mx- 2 doses/ddoses/d
DRUGS EFFECTIVE IN ACUTE TREATMENT OF MIGRAINEDRUGS EFFECTIVE IN ACUTE TREATMENT OF MIGRAINE
DOPAMINE ANTAGONISTDOPAMINE ANTAGONIST
ORALORAL
MetoclopramideMetoclopramide Reglan,genericReglan,generic 5-5-10 mg/d10 mg/d
ProchlorperazineProchlorperazine Compazine,Compazine, 1-25mg/d1-25mg/d
PARENTERALPARENTERAL
ChlorpromazineChlorpromazine genericgeneric0.1 mg/kg IV at 2 mg0.1 mg/kg IV at 2 mg/min mx 35mg/d/min mx 35mg/d MetoclopramideMetoclopramide ReglanReglan
10mg IV10mg IV
ProchlorperazineProchlorperazine CompazineCompazine 10 mg/IV10 mg/IV
DRUGS EFFECTIVE IN PROPHYLACTIC TREATMENT OF DRUGS EFFECTIVE IN PROPHYLACTIC TREATMENT OF MIGRAINEMIGRAINE
DRUGDRUG TRADE NAMETRADE NAME DOSAGEDOSAGE
B- Adrenergic agentsB- Adrenergic agents
PropranololPropranolol
TimololTimolol
AnticonvulsantAnticonvulsant
Sodium valproateSodium valproate
Tricyclic antidepressantTricyclic antidepressant
AmitriptylineAmitriptyline
NortriptylineNortriptyline
Monoamine oxidase Monoamine oxidase inhibitorinhibitor
PhenelzinePhenelzine
IsocarboxazidIsocarboxazid
Serotonergic drugsSerotonergic drugs
MethysergideMethysergide
CyproheptadineCyproheptadine
OtherOther
VerapamilVerapamil
InderalInderal
BlocadrenBlocadren
DepakoteDepakote
Elavil, genericElavil, generic
PamelorPamelor
NardilNardil
MarplanMarplan
SansertSansert
PeriactinPeriactin
IsoptinIsoptin
80-320mg qd80-320mg qd
20-60 mg qd20-60 mg qd
250 mg bid 250 mg bid (mx:1000mg/d)(mx:1000mg/d)
10-5-mg qhs10-5-mg qhs
25-75 mg qhs25-75 mg qhs
15 mg qd15 mg qd
10 mg qd10 mg qd
4-8 mg qd4-8 mg qd
4-16 mg qd4-16 mg qd
40-240 mg qd40-240 mg qd